{"symbol": "ALRN", "companyName": "Aileron Therapeutics Inc.", "exchange": "NASDAQ Global Market", "industry": "Biotechnology", "website": "http://www.aileronrx.com", "description": "Aileron Therapeutics Inc is a clinical-stage biopharmaceutical company that is focused on developing and commercializing a novel class of therapeutics called stapled peptides. The company's lead candidate is ALRN-6924.", "CEO": "Manuel C. Aivado", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}